Tubercular Retinal Vasculitis: Diagnostic Dilemma and Management Strategies

References

• World Health Organization [homepage on internet]. Tuberculosis. Available from: https://www.who.int/news-room/fact-sheets/detail/tuberculosis. Accessed September 15, 2021.
   Google Scholar
• Rajpal S, Arora VK. Latent TB (LTBI) treatment: challenges in India with an eye on 2025: “To Treat LTBI or not to treat, that is the question”. Indian J Tuberc. 2020;67(4S):S43–S47. doi:10.1016/j.ijtb.2020.09.028
   Google Scholar
• World Health Organization [homepage on internet]. Global tuberculosis report; 2020. Available from: https://www.who.int/teams/global-tuberculosis-programme/tb-reports/global-tuberculosis-report-2020. Accessed September 15, 2021.
   Google Scholar
• Betzler BK, Gupta V, Agrawal R. Clinics of ocular tuberculosis: a review. Clin Exp Ophthalmol. 2021;49(2):146–160. doi:10.1111/ceo.13847
   PubMed Web of Science ®Google Scholar
• Dalvin LA, Smith WM. Intraocular manifestations of mycobacterium tuberculosis: a review of the literature. J Clin Tuberc Other Mycobact Dis. 2017;7:13–21. doi:10.1016/j.jctube.2017.01.003
   PubMedGoogle Scholar
• Agrawal R, Testi I, Mahajan S, et al. Collaborative ocular tuberculosis study consensus guidelines on the management of tubercular Uveitis—Report 1. Ophthalmology. 2021;128(2):266–276. doi:10.1016/j.ophtha.2020.01.008
   PubMed Web of Science ®Google Scholar
• Rosenbaum JT, Van Gelder RN. Tautologies and the Telltale Tubercle Bacillus. Ophthalmology. 2021;128(2):288–289. doi:10.1016/j.ophtha.2020.11.005
   Web of Science ®Google Scholar
• Wroblewski KJ, Hidayat AA, Neafie RC, Rao NA, Zapor M. Ocular tuberculosis: a clinicopathologic and molecular study. Ophthalmology. 2011;118(4):772–777. doi:10.1016/j.ophtha.2010.08.011
   PubMed Web of Science ®Google Scholar
• Bansal R, Gupta A, Agarwal R, et al. Role of CT chest and cytology in differentiating tuberculosis from presumed sarcoidosis in uveitis. Ocul Immunol Inflamm. 2019;27(7):1041–1048. doi:10.1080/09273948.2018.1425460
   PubMed Web of Science ®Google Scholar
• Kharel Sitaula R, Iyer V, Noronha V, Dutta Majumder P, Biswas J. Role of high-resolution computerized tomography chest in identifying tubercular etiology in patients diagnosed as Eales’ disease. J Ophthalmic Inflamm Infect. 2017;7(1):4. doi:10.1186/s12348-016-0120-1
   Google Scholar
• Agrawal R, Gunasekeran DV, Grant R, et al. Clinical features and outcomes of patients with Tubercular Uveitis treated with antitubercular therapy in the Collaborative Ocular Tuberculosis Study (COTS)-1 [published correction appears in JAMA Ophthalmol. 2019 Feb 1;137(2):233]. JAMA Ophthalmol. 2017;135(12):1318–1327. doi:10.1001/jamaophthalmol.2017.4485
   PubMed Web of Science ®Google Scholar
• Rosenbaum JT, Sibley CH, Lin P. Retinal vasculitis. Curr Opin Rheumatol. 2016;28(3):228–235. doi:10.1097/BOR.0000000000000271
   PubMed Web of Science ®Google Scholar
• Graham EM, Stanford MR, Whitcup SM. Retinal vasculitis. In: Pepose JS, Holland GN, Wilhelmus KR, editors. Ocular Infection and Immunity. St. Louis: Mosby; 1996:538–551.
   Google Scholar
• El-Asrar AM, Herbort CP, Tabbara KF. A clinical approach to the diagnosis of retinal vasculitis. Int Ophthalmol. 2010;30(2):149–173. doi:10.1007/s10792-009-9301-3
   PubMedGoogle Scholar
• Shukla D, Namperumalsamy P. Eales Disease. In: Schachat AP, Wilkinson CP, Hinton DR, Wiedemann P, editors. Ryan’s Retina. 6th ed. Edinburgh; New York: Elsevier; 2018:1665–1670.
   Google Scholar
• Agrawal R, Gunasekeran DV, Gonzalez-Lopez JJ, et al. Peripheral retinal vasculitis: analysis of 110 consecutive cases and a contemporary reappraisal of tubercular etiology. Retina. 2017;37(1):112–117. doi:10.1097/IAE.0000000000001239
   PubMed Web of Science ®Google Scholar
• Agarwal A, Karkhur S, Aggarwal K, et al. Epidemiology and clinical features of inflammatory retinal vascular occlusions: pooled data from two tertiary-referral institutions. Clin Exp Ophthalmol. 2018;46(1):62–74. doi:10.1111/ceo.12997
   PubMed Web of Science ®Google Scholar
• Kawali A, Bavaharan B, Sanjay S, Mohan A, Mahendradas P, Shetty B. A long-term follow-up of retinal vasculitis – Do they develop systemic disease? Ocul Immunol Inflamm. 2020;28(8):1181–1186. doi:10.1080/09273948.2019.1697455
   PubMed Web of Science ®Google Scholar
• Petrushkin H, Sethi C, Potter J, et al. Developing a pathway for the diagnosis and management of ocular tuberculosis. The pan-London ocular tuberculosis pathway-LOOP. Eye. 2020;34(5):805–808. doi:10.1038/s41433-019-0543-7
   Web of Science ®Google Scholar
• Agrawal R, Testi I, Bodaghi B, et al. Collaborative ocular tuberculosis study consensus guidelines on the management of Tubercular Uveitis-Report 2: guidelines for Initiating antitubercular therapy in anterior uveitis, intermediate uveitis, panuveitis, and retinal vasculitis. Ophthalmology. 2021;128(2):277–287. doi:10.1016/j.ophtha.2020.06.052
   PubMed Web of Science ®Google Scholar
• Shukla D. Re: agrawal et al.: collaborative ocular tuberculosis study consensus guidelines on the management of tubercular uveitis - Report 2: guidelines for initiating antitubercular therapy in anterior uveitis, intermediate uveitis, panuveitis, and retinal vasculitis (Ophthalmology. 2021;128:277–287). Ophthalmology. 2021;128(7):e34–e35. doi:10.1016/j.ophtha.2021.03.024
   Web of Science ®Google Scholar
• Gunasekeran DV, Agrawal R, Agarwal A, et al. The Collaborative Ocular Tuberculosis Study (COTS)-1: a multinational review of 251 patients with tubercular retinal vasculitis. Retina. 2019;39(8):1623–1630. doi:10.1097/IAE.0000000000002194
   PubMed Web of Science ®Google Scholar
• Singh R, Toor P, Parchand S, Sharma K, Gupta V, Gupta A. Quantitative polymerase chain reaction for Mycobacterium tuberculosis in so-called Eales’ disease. Ocul Immunol Inflamm. 2012;20(3):153–157. doi:10.3109/09273948.2012.658134
   PubMed Web of Science ®Google Scholar
• Bansal R, Moharana B, Katoch D, Gupta V, Dogra MR, Gupta A. Outcome of pars plana vitrectomy in patients with retinal detachments secondary to retinal vasculitis. Indian J Ophthalmol. 2020;68(9):1905–1911. doi:10.4103/ijo.IJO_551_20
   Web of Science ®Google Scholar
• Kaza H, Modi R, Rana R, et al. Effect of adjunctive pars plana vitrectomy on focal posterior segment inflammation: a case-control study in tuberculosis-associated uveitis. Ophthalmol Retina. 2018;2(11):1163–1169. doi:10.1016/j.oret.2018.05.002
   PubMedGoogle Scholar
• Bansal R, Dogra M, Chawla R, Kumar A. Pars plana vitrectomy in uveitis in the era of microincision vitreous surgery. Indian J Ophthalmol. 2020;68(9):1844–1851. doi:10.4103/ijo.IJO_1625_20
   PubMed Web of Science ®Google Scholar
• Patel SS, Saraiya NV, Tessler HH, Goldstein DA. Mycobacterial ocular inflammation: delay in diagnosis and other factors impacting morbidity. JAMA Ophthalmol. 2013;131(6):752–758. doi:10.1001/jamaophthalmol.2013.71
   PubMed Web of Science ®Google Scholar
• George RK, Walton RC, Whitcup SM, Nussenblatt RB. Primary retinal vasculitis. Systemic associations and diagnostic evaluation. Ophthalmology. 1996;103(3):384–389. doi:10.1016/s0161-6420(96)30681-7
   PubMed Web of Science ®Google Scholar
• Gupta P, Biswas J. Further evidence of the association of latent Mycobacterium tuberculosis in Eales’ disease. Int Ophthalmol. 2021;41(3):901–906. doi:10.1007/s10792-020-01645-5
   PubMed Web of Science ®Google Scholar
• Kaza H, Tyagi M, Pathengay A, Basu S. Clinical predictors of tubercular retinal vasculitis in a high-endemic country. Retina. 2021;41(2):438–444. doi:10.1097/IAE.0000000000002829
   Web of Science ®Google Scholar
• Kelgaonkar A, Govindhari V, Khalsa A, Basu S. Anti-tubercular therapy alone for treatment of isolated tubercular retinal vasculitis [published online ahead of print, 2021 Aug 9]. Eye. 2021. doi:10.1038/s41433-021-01727-3
   Web of Science ®Google Scholar
• Biswas J, Reesha KR, Pal B, Gondhale HP, Kharel Sitaula R. Long-Term outcomes of a large cohort of patients with Eales’ disease. Ocul Immunol Inflamm. 2018;26(6):870–876. doi:10.1080/09273948.2017.1298817
   PubMed Web of Science ®Google Scholar
• Gupta A, Sharma A, Bansal R, Sharma K. Classification of intraocular tuberculosis. Ocul Immunol Inflamm. 2015;23(1):7–13. doi:10.3109/09273948.2014.967358
   PubMed Web of Science ®Google Scholar
• Gupta A, Gupta V, Arora S, Dogra MR, Bambery P. PCR-positive tubercular retinal vasculitis: clinical characteristics and management. Retina. 2001;21(5):435–444. doi:10.1097/00006982-200110000-00004
   PubMed Web of Science ®Google Scholar
• Van Gelder RN. Uveitis-the tortured tale of the tubercle. JAMA Ophthalmol. 2017;135(12):1328–1329. doi:10.1001/jamaophthalmol.2017.3514
   Web of Science ®Google Scholar
• Kee AR, Gonzalez-Lopez JJ, Al-Hity A, et al. Anti-tubercular therapy for intraocular tuberculosis: a systematic review and meta-analysis. Surv Ophthalmol. 2016;61(5):628–653. doi:10.1016/j.survophthal.2016.03.001
   PubMed Web of Science ®Google Scholar
• Agarwal A, Handa S, Aggarwal K, et al. The role of dexamethasone implant in the management of Tubercular Uveitis. Ocul Immunol Inflamm. 2018;26(6):884–892. doi:10.1080/09273948.2017.1400074
   PubMed Web of Science ®Google Scholar
• Jones NP, Sala-Puigdollers A, Stanga PE. Ultra-widefield fundus fluorescein angiography in the diagnosis and management of retinal vasculitis. Eye. 2017;31(11):1546–1549. doi:10.1038/eye.2017.93
   PubMed Web of Science ®Google Scholar
• Shukla D, Kanungo S, Prasad NM, Kim R. Surgical outcomes for vitrectomy in Eales’ disease. Eye. 2008;22(7):900–904. doi:10.1038/sj.eye.6702763
   Web of Science ®Google Scholar